Eyenovia Inc Share Price

NASDAQ: EYEN

$15.80

+5.24

(+49.62%)

as on July 3, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 1 Jul 2025

Eyenovia Inc Stock Performance

as on July 3, 2025 at 1:29 am IST

Day's Low
Day's High
$15.81
Day's Price Range
$15.81
$15.8
-0.06%
Downside
0.06%
Upside
52 Week's Low
52 Week's High
$0.85
52-Week Price Range
$47.33
$15.8
94.62%
Downside
199.54%
Upside

Eyenovia Inc share price movements today

Previous Close: $10.56
Open: $15.81
Volume: 165.0
Day's Low - High: $15.81 - $15.81
52 Week Low - High: $0.85 - $47.33

Eyenovia Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Eyenovia Inc Stock Fundamentals & Key Indicators

Check Eyenovia Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Eyenovia Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Eyenovia Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eyenovia Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Eyenovia Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Eyenovia Inc. Average target price of $2

Eyenovia Inc Share Price Target

Get share price movements and forecasts by analysts on Eyenovia Inc.

What analysts predicted

-690%DOWNSIDE

Target Price

Current Price

$15.8

Analyzed by

10 Analysts

Target

$2.00

Eyenovia Inc target price $2, a slight downside of -690% compared to current price of $15.8. According to 10 analysts rating.

Eyenovia Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	-	-	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	-3	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-5	-5	-6	-7	-7	-10	-11	-7	-19	-3
Net Profit Margin	0.00%	0.00%	0.00%	-612582.05%	-307730.28%	-218748.27%	-48856.13%	-485406.34%	-71031.15%	-23665.31%

Eyenovia Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	2	14	10	0	0
Gross Profit	0	0	0	0	0	1	12	0	0	-3
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-3	-5	-17	-20	-19	-12	-27	-27	-49
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-984.57%	-92.80%	-277.31%	-719859.94%	-86888.57%

Global Institutional Holdings in Eyenovia Inc

Funds	Holdings
UBS Group AG	6.91%
Lasry Marc	1.06%
Virtu Financial LLC	0.8%
Citadel Advisors Llc	0.43%
Geode Capital Management, LLC	0.36%

See all

About Eyenovia Inc

Eyenovia, Inc. is an ophthalmic technology company. The Company is developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform. The Optejet is especially useful in chronic front-of-the-eye diseases due to its potential for superior compliance versus standard eye drops. The Company’s commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi for mydriasis. Mydcombi is an FDA-approved fixed combination of the two pupil dilation drugs, tropicamide and phenylephrine, delivered with its Optejet technology. The product is indicted to induce mydriasis (pupil dilation) for routine diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroLine is its investigational proprietary microdosed version of pilocarpine, an ophthalmic medication that can dose-dependently induce miosis, or contraction of the pupil.

Organisation	Eyenovia Inc
E-voting on shares	Click here to vote

FAQs

What is Eyenovia Inc share price today?

Eyenovia Inc share price today is $15.8 as on July 3, 2025 at 1:29 am IST at the close of the market. Eyenovia Inc share today touched a day high of $15.81 and a low of $15.81.

What is the 52 week high and 52 week low for Eyenovia Inc share?

Eyenovia Inc share touched a 52 week high of $47.33 on October 18, 2024 and a 52 week low of $0.85 on April 9, 2025. Eyenovia Inc stock price today i.e. July 3, 2025 at 1:29 am IST is closed at $15.8,which is 66.62% down from its 52 week high and 1758.82% up from its 52 week low.

How to invest in Eyenovia Inc Stock (EYEN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eyenovia Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eyenovia Inc Shares that will get you 0.0949 shares as per Eyenovia Inc share price of $15.8 per share as on July 3, 2025 at 1:29 am IST.

What is the minimum amount required to buy Eyenovia Inc Stock (EYEN) from India?

Indian investors can start investing in Eyenovia Inc (EYEN) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 4:52 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Eyenovia Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 4:52 am IST). Based on Eyenovia Inc share’s latest price of $15.8 as on July 3, 2025 at 1:29 am IST, you will get 0.6329 shares of Eyenovia Inc. Learn more about fractional shares .